We are live on ! Find out more
APTO

Aptose Biosciences, Inc.
APTO

Delisted

APTO was delisted on the 1st of April, 2025.

Back to rankings

49 hedge funds and large institutions have $14.7M invested in Aptose Biosciences, Inc. in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

280% more call options, than puts

Call options by funds: $38K | Put options by funds: $10K

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

10% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 10

2% more funds holding

Funds holding: 48 → 49 (+1)

22% less capital invested

Capital invested by funds: $18.8M → $14.7M (-$4.07M)

Holders
49
Holders Change
+1
Holders Change %
+2.08%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
11
Reduced
10
Closed
4
Calls
$38K
Puts
$10K
Net Calls
+$28K
Net Calls Change
-$124K

Top Buyers

Rank Fund Capital Flow
1
AC
Annandale Capital
Texas
+$244K
2
CC
Carlson Capital
Texas
+$78.6K
3
Renaissance Technologies
Renaissance Technologies
New York
+$45.8K
4
SPC
Sigma Planning Corp
Michigan
+$44.1K
5
VF
Virtu Financial
New York
+$25.2K

Top Sellers

Rank Fund Capital Flow
1
SMH
Sanders Morris Harris
Texas
-$281K
2
NCM
Nantahala Capital Management
Connecticut
-$264K
3
Morgan Stanley
Morgan Stanley
New York
-$127K
4
VC
Voss Capital
Texas
-$76.9K
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$58K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCA
26
Transcend Capital Advisors
New Jersey
$14K – – –
BFEC
27
Benjamin F. Edwards & Company
Missouri
$12K – – –
SFA
28
Sequoia Financial Advisors
Ohio
$12K – – –
TSS
29
Two Sigma Securities
New York
$11K -$12.4K -36 -47%
Jane Street
30
Jane Street
New York
$11K -$689 -2 -5%
GG
31
Gleason Group
Kentucky
$11K – – –
JAWM
32
J. Arnold Wealth Management
Ohio
$11K +$3.1K +9 +29%
NFSG
33
Newbridge Financial Services Group
Florida
$9K – – –
Royal Bank of Canada
34
Royal Bank of Canada
Ontario, Canada
$9K +$3.45K +10 +45%
WA
35
WealthTrust Axiom
Pennsylvania
$8K – – –
RJA
36
Raymond James & Associates
Florida
$7K – – –
WAM
37
Warberg Asset Management
Illinois
$7K +$8.96K +26 New
FDCDDQ
38
Federation des caisses Desjardins du Quebec
Quebec, Canada
$6.8K – – –
Wells Fargo
39
Wells Fargo
California
$6K – – –
PP
40
PDS Planning
Ohio
$6K +$7.58K +22 New
TRCT
41
Tower Research Capital (TRC)
New York
$5K +$1.38K +4 +25%
HWM
42
HighMark Wealth Management
Minnesota
$3K – – –
BHWM
43
Beaird Harris Wealth Management
Texas
$2K – – –
Osaic Holdings
44
Osaic Holdings
Arizona
$2K – – –
Rockefeller Capital Management
45
Rockefeller Capital Management
New York
$2K – – –
Simplex Trading
46
Simplex Trading
Illinois
$2K +$345 +1 +11%
AIP
47
Almanack Investment Partners
Pennsylvania
$2K +$2.41K +7 New
Northwestern Mutual Wealth Management
48
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
NDSI
49
Newman Dignan & Sheerar Inc
Rhode Island
$11 +$14.5K +42 New
D.E. Shaw & Co
50
D.E. Shaw & Co
New York
– -$58K -174 Closed
1
2
3

APTO Hedge Fund Activity: Q3 2022 in Review

49 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Aptose Biosciences, Inc. (APTO) for Q3 2022, worth a combined $14.7M — down 22% from $18.8M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new APTO positions and 4 closed out — a net gain of 1 holder — while 11 added to existing stakes and 10 trimmed.

The largest buyer was Annandale Capital, adding an estimated $244K. The largest seller was Sanders Morris Harris, cutting an estimated $281K.

  • 49 institutional investors held Aptose Biosciences, Inc. (APTO) as of Q3 2022, up from 48 in Q2 2022.
  • Funds reported $14.7M of Aptose Biosciences, Inc. stock for Q3 2022, down 22% quarter-over-quarter.
  • 5 funds opened new Aptose Biosciences, Inc. positions in Q3 2022 and 4 closed out, a net change of +1 holder.
  • The largest Aptose Biosciences, Inc. buyer in Q3 2022 was Annandale Capital, an estimated $244K added.
  • The largest Aptose Biosciences, Inc. seller in Q3 2022 was Sanders Morris Harris, an estimated $281K sold.

Based on aggregated 13F filings for Q3 2022.